Assessment, surveillance and prognosis in pre-eclampsia

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 25, Issue 4, 2011, Pages 449-462

  Payne, Beth ^a   Magee, Laura A ^a   Von Dadelszen, Peter ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

assessment; PIERS; pre eclampsia; prognosis

Indexed keywords

ADVERSE OUTCOME; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DISEASE SURVEILLANCE; HUMAN; HYPERTENSION; LABORATORY TEST; MATERNAL HYPERTENSION; OUTCOME ASSESSMENT; OXYGEN SATURATION; PATIENT MONITORING; PRACTICE GUIDELINE; PREECLAMPSIA; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; SEVERE HYPERTENSION;

EID: 79960468058     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2011.02.003     Document Type: Review

References (70)

1. World Health Organization, UNICEF, and UNFPA Maternal mortality in 2005: estimates developed by WHO, UNICEF, UNFPA and The World Bank 2007 http://www.who.int/making-pregnancy-safer/documents/9789241596213/en/index.html
2. M.C. Hogan, K.J. Foreman, and M. Naghavi Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards millennium development goal 5 Lancet 375 2010 1609 1623
3. J.P. Souza, J.G. Cecatti, and A. Faundes Maternal near miss and maternal death in the World Health Organization's 2005 global survey on maternal and perinatal health Bull World Health Organ 88 2010 113 119
4. J. Moodley Maternal deaths due to hypertensive disorders in pregnancy: saving mothers report 2002 -2004 Cardiovasc J Afr 18 2007 358 361 (Pubitemid 351300618)
5. E.A. Steegers, P. von Dadelszen, and J.J. Duvekot Pre-eclampsia Lancet 376 2010 631 644
6. M. Silasi, B. Cohen, and S.A. Karumanchi Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia Obstet Gynecol Clin North Am 37 2010 239 253
7. J.R. Barton, J.M. O'brien, and N.K. Bergauer Mild gestational hypertension remote from term: progression and outcome Am J Obstet Gynecol 184 2001 979 983 (Pubitemid 32368119)
8. C.S. Homer, M.A. Brown, and G. Mangos Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension J Hypertens 26 2008 295 302
9. P. Saudan, M.A. Brown, and M.L. Buddle Does gestational hypertension become pre-eclampsia? Br J Obstet Gynaecol 105 1998 1177 1184 (Pubitemid 28526200)
10. B.M. Sibai, and C.L. Stella Diagnosis and management of atypical preeclampsia-eclampsia Am J Obstet Gynecol 200 2009 481.e1 481.e7
11. L.A. Magee, P. von Dadelszen, and S. Chan The control of hypertension in pregnancy study pilot trial BJOG 114 2007 770.e13 770.e20
12. D.J. Tuffnell, D. Jankowicz, and S.W. Lindow Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003 BJOG 112 2005 875 880 (Pubitemid 40896951)
13. B. Jim, S. Sharma, and T. Kebede Hypertension in pregnancy: a comprehensive update Cardiol Rev 18 2010 178 189
14. M. Khashu, M. Narayanan, and S. Bhargava Perinatal outcomes associated with preterm birth at 33 to 36 weeks' gestation: a population-based cohort study Pediatrics 123 2009 109 113
15. B. Haddad, and B.M. Sibai Expectant management in pregnancies with severe pre-eclampsia Semin Perinatol 33 2009 143 151
16. W. Ganzevoort, A. Rep, G.J. Bonsel PETRA investigators Dynamics and incidence patterns of maternal complications in early-onset hypertension of pregnancy BJOG 114 2007 741 750 (Pubitemid 46788639)
17. L.A. Magee, P.J. Yong, and V. Espinosa Expectant management of severe preeclampsia remote from term: a structured systematic review Hypertens Pregnancy 28 2009 312 347
18. W. Ganzevoort, A. Rep, J.I. de Vries PETRA-investigators Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy Am J Obstet Gynecol 195 2006 495 503 (Pubitemid 44142383)
19. A.E. Bombrys, J.R. Barton, and M. Habli Expectant management of severe preeclampsia at 27(0/7) to 33(6/7) weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management Am J Perinatol 26 2009 441 446
20. A.E. Bombrys, J.R. Barton, and E.A. Nowacki Expectant management of severe preeclampsia at less than 27 weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management Am J Obstet Gynecol 199 2008 247.e1 247.e6
21. L.A. Magee, M.E. Helewa, and J.M. Moutquin SOGC guidelines; diagnosis, evaluation and management of the hypertensive disorders of preganacy J Obstet Gynaecol Can 30 3 suppl 2008 1 48
22. S.A. Lowe, M.A. Brown, and G.A. Dekker Guidelines for the management of hypertensive disorders of pregnancy 2008 Aust N Z J Obstet Gynaecol 49 2009 242 246
23. M.D. Lindheimer, S.J. Taler, F.G. Cunningham American Society of Hypertension ASH position paper: hypertension in pregnancy J Clin Hypertens (Greenwich) 11 2009 214 225
24. National Institute for Health and Clinical Excellence Hypertension in pregnancy: the management of hypertensive disorders during pregnancy (clinical guideline 107) August 2010 http://www.nice.org.uk/nicemedia/live/13098/50418/ 50418.pdf
25. M.A. Brown, M.D. Lindheimer, and M. de Swiet The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) Hypertens Pregnancy 20 2001 IX XIV
26. C. Visintin, M.A. Mugglestone, and M.Q. Almerie Management of hypertensive disorders during pregnancy: summary of NICE guidance BMJ 341 2010 c2207
27. K.G.M. Moons, P. Royston, and Y. Vergouwe Prognosis and prognostic research: what, why, and how? BMJ 338 2009 b375
28. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1982 29 36 (Pubitemid 12142173)
29. V. Bewick, L. Cheek, and J. Ball Statistics review 14: logistic regression Crit Care 9 2005 112 118 (Pubitemid 40246780)
30. R. Jaeschke, G.H. Guyatt, and D.L. Sackett Users' guides to the medical literature.III. How to use an article about a diagnostic test. B. what are the results and will they help me in caring for my patients JAMA 271 1994 703 707 (Pubitemid 24061707)
31. K.G.M. Moons, D.G. Altman, and Y. Vergouwe Prognosis and prognostic research: application and impact of prognostic models in clinical practice BMJ 338 2009 b606
32. R.R. Hansebout, S.D. Cornacchi, and T. Haines How to use an article about prognosis Can J Surg 52 2009 328 336
33. J.N. Martin Jr., B.D. Thigpen, and R.C. Moore Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure Obstet Gynecol 105 2005 246 254 Feb (Pubitemid 40229437)
34. J. Menzies, L.A. Magee, and Y.C. Macnab Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes Hypertens Pregnancy 26 2007 447 462 (Pubitemid 350232904)
35. J. Zhang, M.A. Klebanoff, and J.M. Roberts Prediction of adverse outcomes by common definitions of hypertension in pregnancy Obstet Gynecol 97 2001 261 267 (Pubitemid 32126343)
36. J. Menzies, P. von Dadelszen PIERS Study Grp The PIERS (Pre-Eclampsia Integrated Estimate of Risk) models: univariable and cluster analyses Hypertens Pregnancy 27 2008 620-620
37. P. von Dadelszen, and L.A. Magee Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis J Obstet Gynaecol Can 24 2002 941 945
38. P. von Dadelszen, M.P. Ornstein, and S.B. Bull Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis Lancet 355 2000 87 92 (Pubitemid 30068551)
39. M.D. Lindheimer, and D. Kanter Interpreting abnormal proteinuria in pregnancy: the need for a more pathophysiological approach Obstet Gynecol 115 2010 365 375
40. A.M. Cote, T. Firoz, and A. Mattman The 24-hour urine collection: gold standard or historical practice? Am J Obstet Gynecol 199 2008 625.e1 625.e6
41. A.M. Cote, M.A. Brown, and E. Lam Diagnostic accuracy of urinary spot protein: creatinine ratio for proteinuria in hypertensive pregnant women: systematic review BMJ 336 2008 1003 1006 (Pubitemid 351656092)
42. P. Chan, M. Brown, and J.M. Simpson Proteinuria in pre-eclampsia: how much matters? Bjog-an International J Obstet Gynaecol 112 2005 280 285 (Pubitemid 40314001)
43. S. Thangaratinam, A. Coomarasamy, and F. O'Mahony Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review BMC Med 7 2009 10
44. Payne B, Magee LA, Cté AM et al.; for the PIERS group. PIERS proteinuria: relationship with adverse maternal and perinatal outcome. J Obstet Gynaecol Can 2011; 33: xxx-xxx (in press).
45. R. Romero, M. Mazor, and C.J. Lockwood Clinical significance, prevalence, and natural history of thrombocytopenia in pregnancy-induced hypertension Am J Perinatol 6 1989 32 38 (Pubitemid 19053821)
46. M.A. Brown, and M.L. Buddle Hypertension in pregnancy: maternal and fetal outcomes according to laboratory and clinical features Med J Aust 165 1996 360 365 (Pubitemid 26354152)
47. S. Laskin, B. Payne, J. Hutcheon PIERS Study Group The role of platelet counts in the assessment on inpatient women with pre-eclampsia Pregnancy Hypertens 1 2010 S7
48. J.N. Martin Jr., W.L. May, and E.F. Magann Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity Am J Obstet Gynecol 180 1999 1407 1414 (Pubitemid 29293259)
49. B. Haddad, J.R. Barton, and J.C. Livingston Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome Am J Obstet Gynecol 183 2000 444 448 (Pubitemid 30651095)
50. S. Cavkaytar, E.N. Ugurlu, and A. Karaer Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome? Acta Obstet Gynecol Scand 86 2007 648 651 (Pubitemid 46801803)
51. S.J. Benton, P. von Dadelszen PIERS (Pre-eclampsia Integrated Estimate of RiSk) Study Group Abnormal liver tests as predictors for adverse maternal outcomes in women with pre-eclampsia Pregnancy Hypertens 1 2010 P88
52. A.C. Martin, and M.A. Brown Could uric acid have a pathogenic role in pre-eclampsia? Nat Rev Nephrol 6 2010 744 748
53. K.P. Williams, and F. Galerneau The role of serum uric acid as a prognostic indicator of the severity of maternal and fetal complications in hypertensive pregnancies J Obstet Gynaecol Can 24 2002 628 632
54. S. Thangaratinam, K.M.K. Ismail, and S. Sharp TIPPS review group. Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review BJOG 113 2006 369 378
55. M. Parrish, M. Griffin, and R. Morris Hyperuricemia facilitates the prediction of maternal and perinatal adverse outcome in patients with severe/superimposed preeclampsia J Matern Fetal Neonatal Med 23 2010 1451 1455
56. T. Pedersen, A.M. Moller, and K. Hovhannisyan Pulse oximetry for perioperative monitoring Cochrane Database of Syst Rev 2009 (4):CD002013
57. C. De Felice, L. Leoni, and E. Tommasini Maternal pulse oximetry perfusion index as a predictor of early adverse respiratory neonatal outcome after elective cesarean delivery Pediatr Crit Care Med 9 2008 203 208 (Pubitemid 351355033)
58. J.W. VanHook, C.J. Harvey, and G.D. Anderson Effect of pregnancy on maternal oxygen saturation values: u se of reflectance pulse oximetry during pregnancy South Med J 89 1996 1188 1192 (Pubitemid 27020641)
59. Millman A, Payne B, von Dadelszen P. Oxygen saturation as a predictor of outcomes in women with pre-eclampsia. J Obstet Gynaecol Can (in press).
60. W.B. Kannel, D. Mcgee, and T. Gordon General cardiovascular risk profile - framingham study Am J Cardiol 38 1976 46 51
61. D.T. Wong, and W.A. Knaus Predicting outcome in critical care: the current status of the apache prognostic scoring system Can J Anaesth 38 1991 374 383
62. D.K. Richardosn, J.D. Corcoran, and G.J. Escobar SNAP-II and SNAPPE-II: simplified newborn illness severity and mortality risk scores J Pediatr 138 2001 92 100 (Pubitemid 32097148)
63. P. von Dadelszen, L.A. Magee, and R.M. Devarakonda The prediction of adverse maternal outcomes in preeclampsia J Obstet Gynaecol Can 26 2004 871 879
64. P. von Dadelszen, B. Payne, and J. li Prediction of adverse maternal outcomes in pre-eclampsia: the fullPIERS model: development and validation Lancet 377 2011 219 227
65. B. Brown, S.W. Cochran, and O. Helmer An evaluation of methodology of Delphi technique Biometrics 23 1967 600
66. A. Hutchinson, and P. Fowler Outcome measures for primary health care: what are the research priorities Br J Gen Pract 42 1992 227 231
67. The PIERS Study Group. Pre-eclampsia Integrated Estimate of RiSk (PIERS). Child and family research institute; https://piers.cfri.ca.
68. J. Menzies, L.A. Magee, and J. Li Instituting surveillance guidelines and adverse outcomes in preeclampsia Obstet Gynecol 110 2007 121 127 (Pubitemid 47015710)
69. P. von Dadelszen, D. Sawchuck, and R. McMaster The active implementation of pregnancy hypertension guidelines in British Columbia Obstet Gynecol 116 2010 659 666
70. D.G. Altman, Y. Vergouwe, and P. Royston Prognosis and prognostic research: validating a prognostic model BMJ 338 2009 b605